ArticleJugan geon-gang gwa jilbyeong2024
[Prevalence of Sarcopenia in the Republic of Korea].
Article in Jugan geon-gang gwa jilbyeong, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association of Protein Intake with Sarcopenia and Related Indicators Among Korean Older Adults: A Systematic Review and Meta-Analysis.Nutrients · 2024Pooled it
- Associations of magnesium intake and a magnesium-rich diet score with sarcopenia in middle-aged and older Korean adults: potential mediation by C-reactive protein.Frontiers in nutrition · 2026Article
- AI-Enhanced Lower Extremity X-Ray Segmentation: A Promising Tool for Sarcopenia Diagnosis.Healthcare (Basel, Switzerland) · 2025Article
- [A decision tree-based prediction model for hearing loss in middle-aged and older adults: Secondary analysis of the Korea National Health and Nutrition Examination Survey].Journal of Korean gerontological nursing · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of low handgrip strength and sarcopenia in people aged ≥65, in the Republic of Korea, was investigated using data from the Korea National Health and Nutrition Examination Survey (KNHANES). This study included participants in the 2022 KNHANES aged ≥65 years who had handgrip strength and muscle mass measured by bioelectrical impedance analysis, according to the Asian Working Group for Sarcopenia 2019 guidelines. In 2022, prevalence of low handgrip strength among those aged ≥65 was 14.2% for men and 18.8% for women, and the prevalence of sarcopenia was 6.6% for men and 9.2% for women. In this study, the prevalence of sarcopenia was higher in older age, women than in men, and low-income groups. In conclusion, older people and those with in low-income groups are vulnerable to sarcopenia; therefore, it is necessary to focus on early identification of sarcopenia and development of prevention and management intervention programs for these people.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.